PTPN9
Tyrosine-protein phosphatase non-receptor type 9
Also known as: MEG2, PTN9_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P43378
- Gene
- PTPN9
- Ensembl
- ENSG00000169410
- Chromosome
- 15
- Canonical length
- 593 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains an N-terminal domain that shares a significant similarity with yeast SEC14, which is a protein that has phosphatidylinositol transfer activity and is required for protein secretion through the Golgi complex in yeast. This PTP was found to be activated by polyphosphoinositide, and is thought to be involved in signaling events regulating phagocytosis. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
593 residues, UniProt reviewed canonical sequence.
>P43378|PTPN9
1 MEPATAPRPD MAPELTPEEE QATKQFLEEI NKWTVQYNVS PLSWNVAVKF LMARKFDVLR
61 AIELFHSYRE TRRKEGIVKL KPHEEPLRSE ILSGKFTILN VRDPTGASIA LFTARLHHPH
121 KSVQHVVLQA LFYLLDRAVD SFETQRNGLV FIYDMCGSNY ANFELDLGKK VLNLLKGAFP
181 ARLKKVLIVG APIWFRVPYS IISLLLKDKV RERIQILKTS EVTQHLPREC LPENLGGYVK
241 IDLATWNFQF LPQVNGHPDP FDEIILFSLP PALDWDSVHV PGPHAMTIQE LVDYVNARQK
301 QGIYEEYEDI RRENPVGTFH CSMSPGNLEK NRYGDVPCLD QTRVKLTKRS GHTQTDYINA
361 SFMDGYKQKN AYIGTQGPLE NTYRDFWLMV WEQKVLVIVM TTRFEEGGRR KCGQYWPLEK
421 DSRIRFGFLT VTNLGVENMN HYKKTTLEIH NTEERQKRQV THFQFLSWPD YGVPSSAASL
481 IDFLRVVRNQ QSLAVSNMGA RSKGQCPEPP IVVHCSAGIG RTGTFCSLDI CLAQLEELGT
541 LNVFQTVSRM RTQRAFSIQT PEQYYFCYKA ILEFAEKEGM VSSGQNLLAV ESQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PTPN9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 15 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 15 nTPM
- small intestine: 10 nTPM
- seminal vesicle: 9.7 nTPM
- duodenum: 9.5 nTPM
- colon: 9.3 nTPM
- placenta: 9.3 nTPM
Single-cell type
- podocytes: 212 nCPM
- renal collecting duct intercalated cells: 129 nCPM
- proximal tubule cells: 123 nCPM
- loop of henle epithelial cells: 105 nCPM
- papillary tip epithelial cells: 80 nCPM
- renal collecting duct principal cells: 79 nCPM
Immune cell
- basophil: 2.4 nTPM
- NK-cell: 2 nTPM
- gdT-cell: 1.9 nTPM
- intermediate monocyte: 1.9 nTPM
- non-classical monocyte: 1.7 nTPM
- memory CD8 T-cell: 1.6 nTPM
Brain region
- medulla oblongata: 19 nTPM
- hypothalamus: 18 nTPM
- cerebral cortex: 17 nTPM
- hippocampal formation: 17 nTPM
- basal ganglia: 16 nTPM
- amygdala: 15 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.46
- gnomAD pLI
- 0.11
- gnomAD missense Z
- 2.1
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of neuron projection development
- peptidyl-tyrosine dephosphorylation
- positive regulation of protein localization to plasma membrane
- protein dephosphorylation
- signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Tyrosine-specific protein phosphatase, PTPase domain
- Tyrosine-specific protein phosphatases domain
- CRAL-TRIO lipid binding domain
- Protein-tyrosine phosphatase, catalytic
- CRAL/TRIO, N-terminal domain
- Protein-tyrosine phosphatase, active site
- Protein-tyrosine phosphatase-like
- CRAL/TRIO, N-terminal domain superfamily
- CRAL-TRIO lipid binding domain superfamily
- Protein-Tyrosine Phosphatase
- Protein-tyrosine phosphatase
- CRAL/TRIO domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PTPN9 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PTPN9 as an antibody target. Whether an autoantibody or antibody against PTPN9 could matter depends on whether native PTPN9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PTPN9 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PTPN9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...